T2DM Initially Remits in Majority Who Undergo Gastric Bypass
THURSDAY, Feb. 7, 2019 -- Roux-en-Y gastric bypass (RYGB) is associated with high levels of type 2 diabetes remission at one year, although 27 percent relapse after five years, according to a study published online Feb. 6 in Diabetologia.
Lene R....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Gastric Bypass | Gastroenterology | Pharmaceuticals | Study